key: cord-0792876-vx38qw6n
authors: Markert, Udo R.; Szekeres-Bartho, Julia; Schleußner, Ekkehard
title: Adverse effects on female fertility from vaccination against COVID-19 unlikely
date: 2021-09-21
journal: J Reprod Immunol
DOI: 10.1016/j.jri.2021.103428
sha: 995d607ae8094d17590bd8e61e31dd8af8884d48
doc_id: 792876
cord_uid: vx38qw6n

This opinion paper briefly presents arguments that support the unlikelihood of an impact on female fertility from current covid-19 vaccines.

Vaccination is a success story in modern medicine, yet the number of vaccination critics is increasing (Greenwood 2014). The current COVID-19 pandemic with the resulting fear and uncertainty in the public is also a breeding ground for vaccination opponents (Romer and Jamieson 2020) . Misinformation and conspiracy theories have accompanied the pandemic since its inception, and especially, concerning the newly developed vaccines (Ball and Maxmen 2020). Distinct types of vaccines have been approved or are under development in different countries. Their global aim is the induction of antibody and T cell generation targeting the SARS-CoV-2 spike protein (Park et al. 2021 , Voysey et al. 2021 .

Claims have circulated in social media that these antibodies also act against placental components, leading to infertility (Fauzia 2020). This has led to an enormous public interest in the topic reflected by 34,900% increase of respective internet search terms in the U.S. (Sajjadi et al. 2021) . The suspected target is syncytin-1 (endogenous retrovirus group W member 1, envelope; ERVW-1), mostly localized to villous syncytiotrophoblast. Binding to its main receptor SLC1A5, almost exclusively expressed in villous cytotrophoblast, initiates the fusion process to form the syncytiotrophoblast (Lavillette et al. 2002 , Roberts et al. 2021 ). In the female or male reproductive tract, a lower syncytin-1 expression has been described also for J o u r n a l P r e -p r o o f oocytes, testes, and spermatozoa (Bjerregaard et al. 2014 , Bergallo et al. 2021 ), but also for adrenal tissue, bone marrow, white blood cells, breast, colon, kidney, ovary, prostate, skin, spleen, thymus, thyroid, brain and trachea (de Parseval et al. 2003) . . This protein has an overall homology of 81% with syncytin-1, and even 87% homology with the syncytin-1 surface domain (Laufer et al. 2009 ). Despite the high similarity with MSRV, the therapeutic antibody does not bind to syncytin and has no effect on syncytin functionality in relation to syncytiotrophoblast cell fusion, which is fundamental for normal placental development (Kornmann and Curtin 2020). It may be presumed that a potential antibody against a very short transmembrane sequence would not disturb the functionality of syncytin-1.

In consideration of the suspected generation of anti-syncytin-1 antibodies induced through the SARS-CoV-2 vaccines, a far stronger antibody inducing effect may be expected through the virus itself. In an active infection, the corona spike protein antigen exposure is significantly higher and more incalculable than after vaccination. SARS-CoV-2 infection causes an elevated risk for on average 1 week earlier birth, preterm delivery and newborns that require phototherapy (Dumitriu et al. 2021 , Mirbeyk et al. 2021 ). In the early phase of the pandemic in 2020, it has been reported that SARS-CoV-2 infection does not seem to impact frequency of further pregnancy disorders such as gestational diabetes, preeclampsia, intrauterine growth restriction, preterm rupture of membrane, stillbirth, hemorrhage, neonatal intensive care unit admission or neonatal sepsis (Pirjani et al. 2020 ). These observations have been done on low numbers of patients and do not justify the statement that SARS-CoV-2 infection is not harmful in pregnancy (Mirbeyk et al. 2021) . Thus far, no significantly increased risk of pregnancy loss for women with anti-SARS-CoV-2 antibodies has been reported (la Cour Freiesleben et al. 2021). A recent study has shown that the pregnancy rate upon transfer of in vitro fertilized frozen embryos is not different between vaccinated or recovered anti-SARS-CoV-2 immunoreactive and nonreactive women (Morris 2021) . In 2002/2003, a SARS-CoV (frequently named SARS-CoV-1) pandemic has emerged. This virus expresses the same VVNQN sequence in its spike protein as SARS-CoV-2, and thus, shows the same similarity with syncytin-1, potentially leading to similar antibodies against the respective epitope.

Nonetheless, long-term effects of SARS-CoV on female fertility have not been reported (Segars et al. 2020) .

Therefore, from the perspective of reproductive medicine and placental research, the widespread claims concerning fertility disturbing effects through COVID-19 vaccines

Analysis of transcribed human endogenous retrovirus w env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences

The envelope glycoprotein of human endogenous retrovirus type w uses a divergent family of amino acid transporters/cell surface receptors

A systematic review of pregnant women with covid-19 and their neonates

Sars-cov-2 spike protein seropositivity from vaccination or infection does not cause sterility

Non-viral covid-19 vaccine delivery systems

Maternal and neonatal outcomes in covid-19 infected pregnancies: A prospective cohort study

Conspiracy theories as barriers to controlling the spread of covid-19 in the u

United states internet searches for "infertility" following covid-19 vaccine misinformation

Prior and novel coronaviruses, coronavirus disease 2019 (covid-19), and human reproduction: What is known?

Safety and efficacy of the chadox1 ncov-19 vaccine (azd1222) against sars-cov-2: An interim analysis of four randomised controlled trials in brazil, south africa, and the uk